Inflammatory Myeloradiculitis Secondary to Pembrolizumab: A Case Report and Literature Review

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Database</td><td class="align_center">Results</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">PubMed</td><td class="align_center">65</td></tr><tr><td class="align_left">Embase</td><td class="align_center">234</td></tr><tr><td class="align_left">Web of Science</td><td class="align_center">36</td></tr><tr><td class="align_left">Scopus</td><td class="align_center">107</td></tr><tr><td class="align_left">Cochrane Central</td><td class="align_center">4</td></tr><tr><td class="align_left">CINAHL</td><td class="align_center">10</td></tr><tr><td class="align_left">Total</td><td class="align_center">456</td></tr><tr><td class="align_left">After duplicates removed</td><td class="align_center">281</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Case Reports in Oncological Medicine

tab3

Table 3

Table 3: Inflammatory Myeloradiculitis Secondary to Pembrolizumab: A Case Report and Literature Review 